- Home
- TFIN vs CDNA Comparison
TFIN vs CDNA Comparison
Compare TFIN & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TFIN
- CDNA
- Stock Information
- Founded
- TFIN 1981
- CDNA 1998
- Country
- TFIN United States
- CDNA United States
- Employees
- TFIN 1553
- CDNA N/A
- Industry
- TFIN Major Banks
- CDNA Medical Specialities
- Sector
- TFIN Finance
- CDNA Health Care
- Exchange
- TFIN Nasdaq
- CDNA Nasdaq
- Market Cap
- TFIN 1.1B
- CDNA 1.1B
- IPO Year
- TFIN N/A
- CDNA 2014
- Fundamental
- Price
- TFIN $52.65
- CDNA $18.48
- Analyst Decision
- TFIN Hold
- CDNA Buy
- Analyst Count
- TFIN 6
- CDNA 8
- Target Price
- TFIN $68.50
- CDNA $28.14
- AVG Volume (30 Days)
- TFIN 331.3K
- CDNA 649.0K
- Earning Date
- TFIN 04-16-2025
- CDNA 04-30-2025
- Dividend Yield
- TFIN N/A
- CDNA N/A
- EPS Growth
- TFIN N/A
- CDNA N/A
- EPS
- TFIN 0.37
- CDNA 0.93
- Revenue
- TFIN $401,390,000.00
- CDNA $333,785,000.00
- Revenue This Year
- TFIN $17.41
- CDNA $13.28
- Revenue Next Year
- TFIN $12.72
- CDNA $15.13
- P/E Ratio
- TFIN $141.86
- CDNA $19.83
- Revenue Growth
- TFIN 0.68
- CDNA 19.07
- 52 Week Low
- TFIN $42.90
- CDNA $7.42
- 52 Week High
- TFIN $110.58
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- TFIN 46.17
- CDNA 49.91
- Support Level
- TFIN $42.90
- CDNA $17.78
- Resistance Level
- TFIN $52.26
- CDNA $19.50
- Average True Range (ATR)
- TFIN 4.05
- CDNA 1.25
- MACD
- TFIN 0.69
- CDNA 0.12
- Stochastic Oscillator
- TFIN 77.88
- CDNA 62.07
About TFIN Triumph Financial Inc.
Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.